Company page

Procept Biorobotics Corporation

Procept Biorobotics Corporation, trading under the ticker PRCT, operates in the American market with a market capitalization of approximately $950 million. The company focuses on developing innovative robotic solutions for urological procedures. Its advanced technologies aim to enhance surgical outcomes and improve patient care in the field of urology.

PRCT:NASDAQUpdated August 14, 2026
Procept Biorobotics Corporation logo
Ticker
PRCT:NASDAQ
Asset type
Stock
Market cap
$1.24B
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD